Hartis-Pharma is a Swiss-based biotech company with clinical-stage ready compound in Sickle Cell Disease (SCD). We aim to develop treatments against diseases and disease complications due to decreased HDL functions.
Company Details
- Founded
- 2016
- Address
- 13c Chemin De Bonmont, Nyon,vaud 1260,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- hartispharma.com
- Keywords
- Biotech, Sickle Cell Disease, HDL.
- HQ
- Nyon, Vaud
Hartis Pharma Questions
Hartis Pharma's website is hartispharma.com
Hartis Pharma's LinkedIn profile is https://ch.linkedin.com/company/hartispharma
Hartis Pharma's industry is
Biotechnology Research
Hartis Pharma's top competitors are
Novartis,
Beyond △ Movement By Markus Kneissl,
Elanix Biotechnologies Sa,
Exlitis Médiation,
Synendos Therapeutics Ag,
Mpx International Corporation,
Effik Suisse,
Engimmune Therapeutics,
Alentis Therapeutics,
Endogena Therapeutics, Inc..
Hartis Pharma's categories are Biotechnology Research
Hartis Pharma's founding year is 2016
